AJP - Endo AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 293: E70-E74, 2007. First published March 13, 2007; doi:10.1152/ajpendo.00259.2006
0193-1849/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/E70    most recent
00259.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miles, P. D.
Right arrow Articles by Barlow, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miles, P. D.
Right arrow Articles by Barlow, C.

Impaired insulin secretion in a mouse model of ataxia telangiectasia

Philip D. Miles,1 Kai Treuner,2 Marc Latronica,2 Jerrold M. Olefsky,1 and Carrolee Barlow2

1Division of Endocrinology and Metabolism, Department of Medicine, University of California San Diego, La Jolla; and 2Laboratory of Genetics, Salk Institute for Biological Studies, La Jolla, California

Submitted 29 May 2006 ; accepted in final form 14 December 2006

Ataxia telangiectasia (A-T) is an autosomal recessive disease caused by mutations in the A-T mutated (ATM) gene. The gene encodes a serine/threonine kinase with important roles in the cellular response to DNA damage, including the activation of cell cycle checkpoints and induction of apoptosis. Although these functions might explain the cancer predisposition of A-T patients, the molecular mechanisms leading to glucose intolerance and diabetes mellitus (DM) are unknown. We have investigated the pathogenesis of DM in a mouse model of A-T. Here we show that young Atm-deficient mice show normal fasting glucose levels and normal insulin sensitivity. However, oral glucose tolerance testing revealed delayed insulin secretion and resulting transient hyperglycemia. Aged Atm–/– mice show a pronounced increase in blood glucose levels and a decrease in insulin and C-peptide levels. Our findings support a role for ATM in metabolic function and point toward impaired insulin secretion as the primary cause of DM in A-T.

Atm–/– mice; diabetes mellitus



Address for reprint requests and other correspondence: C. Barlow, BrainCells, Inc., 10835 Road to the Cure, Ste. 150, San Diego, CA 92121 (e-mail: cbarlow{at}braincellsinc.com)




This article has been cited by other articles:


Home page
BioinformaticsHome page
R. I. Sadreyev, J. D. Feramisco, H. Tsao, and N. V. Grishin
Phenotypic categorization of genetic skin diseases reveals new relations between phenotypes, genes and pathways
Bioinformatics, November 15, 2009; 25(22): 2891 - 2896.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
I. A. Barbazetto, M. Room, N. A. Yannuzzi, G. R. Barile, J. E. Merriam, A. M. C. Bardal, K. B. Freund, L. A. Yannuzzi, and R. Allikmets
ATM Gene Variants in Patients with Idiopathic Perifoveal Telangiectasia
Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 3806 - 3811.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.